A MODEL OF THE PLATELET FACTOR-IV COMPLEX WITH HEPARIN

被引:90
|
作者
STUCKEY, JA [1 ]
CHARLES, RS [1 ]
EDWARDS, BFP [1 ]
机构
[1] WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,540 E CANFIELD AVE,DETROIT,MI 48201
来源
关键词
ALPHA-HELIX; LYSINE RESIDUES; DISACCHARIDE UNITS;
D O I
10.1002/prot.340140213
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A model of heparin bound to bovine platelet factor 4 (BPF4) was completed using a graphically designed heparin molecule and the crystallographic coordinates of the native bovine platelet factor 4 tetramer. The oligosaccharides had a chain length of at least eight disaccharide units with the major repeating disaccharide unit consisting of (1-->4)-O-(alpha-L-idopyranosyluronic acid 2-sulfate)-(1-->4)-(2-deoxy-2-sulfamino-2-D-glucopyranosyl 6-sulfate). Each disaccharide unit carried a -4.0 charge. The structure of BPF4 was solved to 2.6 A resolution with R = 0.237. Each monomer of BPF4 contains an alpha-helix lying across 3 strands of antiparallel beta-sheet. Each helix has four lysines, which have been implicated in heparin binding. These lysine residues are predominantly on one side of the helix and are solvent accessible. Electrostatic calculations performed on the BPF4 tetramer show a ring of strong, positive charge which runs perpendicularly across the helices. Included in this ring of density is His-38, which has been shown by NMR to have a large pK(a) shift when heparin binds to BPF4. Our model of heparin bound to PF4 has the anionic polysaccharide perpendicular to the alpha-helices, wrapped about the tetramer along the ring of positive charge, and salt linked to all four lysines on the helix of each monomer.
引用
收藏
页码:277 / 287
页数:11
相关论文
共 50 条
  • [31] GLOMERULAR LOCALIZATION OF PLATELET FACTOR-IV IN STREPTOCOCCAL NEPHRITIS
    MEZZANO, S
    BURGOS, ME
    ARDILES, L
    OLAVARRIA, F
    CONCHA, M
    CAORSI, I
    ARANDA, E
    MEZZANO, D
    NEPHRON, 1992, 61 (01): : 58 - 63
  • [32] INTERACTION OF PLATELET FACTOR-IV WITH CELLS-INVITRO
    HESS, S
    WATSON, J
    CHECOVICH, W
    ESKO, JD
    MOSHER, DF
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1154 - 1154
  • [33] HEPARIN-RELEASED PLATELET FACTOR-IV (HR-PF4) IN DIABETIC MICROVASCULAR DISEASE
    BOSCHETTI, C
    VICARI, A
    COFRANCESCO, E
    CORTELLARO, M
    DELLAVOLPE, A
    MOREO, G
    POGLIANI, E
    POZZA, G
    POLLI, E
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 189 - 189
  • [34] INVIVO INHIBITION OF MEGAKARYOCYTE AND PLATELET PRODUCTION BY PLATELET FACTOR-IV IN MICE
    HAN, ZC
    BELLUCCI, S
    BODEVIN, E
    WAN, HY
    SHEN, ZX
    CAEN, JP
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1991, 313 (12): : 553 - 558
  • [35] H-1-NMR STUDIES OF BOVINE PLATELET FACTOR-IV - HISTIDINE ASSIGNMENTS AND INTERACTIONS WITH HEPARIN
    TALPAS, CJ
    WALZ, DA
    LEE, L
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1078 (02) : 208 - 218
  • [36] ADVERSE-EFFECTS OF HEPARIN-PROTAMINE COMPLEXES ARE ABSENT FOLLOWING REVERSAL OF ANTICOAGULANT ACTIVITY OF HEPARIN BY PLATELET FACTOR-IV
    COOK, JJ
    YAN, ZQ
    SCHAFFER, L
    STEWART, GJ
    MAIONE, T
    NIEWIAROWSKI, S
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 765 - 765
  • [37] PLATELET FACTOR-IV IS AN INHIBITOR OF BASIC FIBROBLAST GROWTH-FACTOR
    WATSON, JB
    MOSHER, DF
    CIRCULATION, 1992, 86 (04) : 291 - 291
  • [38] PLATELET FACTOR-IV - PRODUCTION, STRUCTURE, AND PHYSIOLOGICAL AND IMMUNOLOGICAL ACTION
    ZUCKER, MB
    KATZ, IR
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1991, 198 (02): : 693 - 702
  • [39] THROMBOXANE, PROSTACYCLIN AND PLATELET FACTOR-IV IN CARDIAC FIBRILLATION PATIENTS
    PANCHENKO, VM
    SMOLYAR, MI
    ZHIVODEROV, VM
    KLINICHESKAYA MEDITSINA, 1991, 69 (07): : 80 - 82
  • [40] PROTEASE-INDUCED IMMUNOREGULATORY ACTIVITY OF PLATELET FACTOR-IV
    KATZ, IR
    THORBECKE, GJ
    BELL, MK
    YIN, JZ
    CLARKE, D
    ZUCKER, MB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (10) : 3491 - 3495